MedTrace Logo

Comparison of the Efficacy of Two Rituximab Treatment Regimens in Patients With Lupus Nephropathy

NCT01765842 · Status: TERMINATED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 9

Last updated 2015-07-10

No results posted yet for this study

Summary

Comparison of the Efficacy of Two Rituximab Treatment Regimens in Patients With Lupus Nephropathy Resistant to Conventional Treatments

Conditions

Interventions

BIOLOGICAL

Rituximab

Only one cycle of rituximab will be administered in this arm.

Sponsors & Collaborators

  • Ministry of Health, Spain

    collaborator OTHER_GOV

  • Fundación Pública Andaluza Progreso y Salud

    lead OTHER

Principal Investigators

  • María Jesús Castillo Palma, PhD · Virgen del Rocío Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-11-30
Primary Completion
2014-11-30
Completion
2015-12-31

Countries

  • Spain

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01765842 on ClinicalTrials.gov